252 related articles for article (PubMed ID: 18498649)
21. Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells.
Komiya K; Sueoka-Aragane N; Sato A; Hisatomi T; Sakuragi T; Mitsuoka M; Sato T; Hayashi S; Izumi H; Tsuneoka M; Sueoka E
J Cancer Res Clin Oncol; 2010 Mar; 136(3):465-73. PubMed ID: 19756735
[TBL] [Abstract][Full Text] [Related]
22. miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer.
Tai MC; Kajino T; Nakatochi M; Arima C; Shimada Y; Suzuki M; Miyoshi H; Yatabe Y; Yanagisawa K; Takahashi T
Carcinogenesis; 2015 Dec; 36(12):1464-73. PubMed ID: 26483346
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas.
Bouillez A; Rajabi H; Pitroda S; Jin C; Alam M; Kharbanda A; Tagde A; Wong KK; Kufe D
Cancer Res; 2016 Mar; 76(6):1538-48. PubMed ID: 26833129
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic silencing of cell adhesion molecule 1 in different cancer progenitor cells of transgenic c-Myc and c-Raf mouse lung tumors.
Reamon-Buettner SM; Borlak J
Cancer Res; 2008 Sep; 68(18):7587-96. PubMed ID: 18794147
[TBL] [Abstract][Full Text] [Related]
25. Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells.
Kidder BL; Yang J; Palmer S
PLoS One; 2008; 3(12):e3932. PubMed ID: 19079543
[TBL] [Abstract][Full Text] [Related]
26. Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1.
Rohrbeck A; Borlak J
PLoS One; 2009 Oct; 4(10):e7315. PubMed ID: 19812696
[TBL] [Abstract][Full Text] [Related]
27. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
[TBL] [Abstract][Full Text] [Related]
28. Effect of budesonide on the methylation and mRNA expression of the insulin-like growth factor 2 and c-myc genes in mouse lung tumors.
Tao L; Li Y; Wang W; Kramer PM; Gunning WT; Lubet RA; Steele VE; Pereira MA
Mol Carcinog; 2002 Oct; 35(2):93-102. PubMed ID: 12325039
[TBL] [Abstract][Full Text] [Related]
29. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.
Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W
Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441
[No Abstract] [Full Text] [Related]
30. lncRNAs and MYC: An Intricate Relationship.
Iaccarino I
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704924
[TBL] [Abstract][Full Text] [Related]
31. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
[TBL] [Abstract][Full Text] [Related]
32. Distinct cellular factors regulate the c-myb promoter through its E2F element.
Campanero MR; Armstrong M; Flemington E
Mol Cell Biol; 1999 Dec; 19(12):8442-50. PubMed ID: 10567569
[TBL] [Abstract][Full Text] [Related]
33. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
Luo Q; Li J; Cenkci B; Kretzner L
Oncogene; 2004 Feb; 23(5):1088-97. PubMed ID: 14716294
[TBL] [Abstract][Full Text] [Related]
34. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
Batsché E; Crémisi C
Oncogene; 1999 Oct; 18(41):5662-71. PubMed ID: 10523846
[TBL] [Abstract][Full Text] [Related]
35. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.
Li Z; Van Calcar S; Qu C; Cavenee WK; Zhang MQ; Ren B
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8164-9. PubMed ID: 12808131
[TBL] [Abstract][Full Text] [Related]
36. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
37. Conserved transcription factor binding sites of cancer markers derived from primary lung adenocarcinoma microarrays.
Yap YL; Lam DC; Luc G; Zhang XW; Hernandez D; Gras R; Wang E; Chiu SW; Chung LP; Lam WK; Smith DK; Minna JD; Danchin A; Wong MP
Nucleic Acids Res; 2005; 33(1):409-21. PubMed ID: 15653641
[TBL] [Abstract][Full Text] [Related]
38. ETS variant transcription factor 5 and c-Myc cooperate in derepressing the human telomerase gene promoter via composite ETS/E-box motifs.
Zhang F; Wang S; Zhu J
J Biol Chem; 2020 Jul; 295(29):10062-10075. PubMed ID: 32518154
[TBL] [Abstract][Full Text] [Related]
39. Transcriptome profiling of human hepatocytes treated with Aroclor 1254 reveals transcription factor regulatory networks and clusters of regulated genes.
Reymann S; Borlak J
BMC Genomics; 2006 Aug; 7():217. PubMed ID: 16934159
[TBL] [Abstract][Full Text] [Related]
40. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.
Iwata T; Schultz D; Hicks J; Hubbard GK; Mutton LN; Lotan TL; Bethel C; Lotz MT; Yegnasubramanian S; Nelson WG; Dang CV; Xu M; Anele U; Koh CM; Bieberich CJ; De Marzo AM
PLoS One; 2010 Feb; 5(2):e9427. PubMed ID: 20195545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
